Skip to main content

Higher Dietary Quality at Breast Cancer Diagnosis Linked to Lower CVD Risk

Medically reviewed by Carmen Pope, BPharm. Last updated on April 23, 2024.

By Elana Gotkine HealthDay Reporter

TUESDAY, April 23, 2024 -- Higher diet quality at diagnosis of breast cancer is associated with a lower risk for cardiovascular disease (CVD) events and death, especially the Dietary Approaches to Stop Hypertension diet quality index, according to a study published online April 17 in JNCI Cancer Spectrum.

Isaac J. Ergas, Ph.D., M.P.H., from Kaiser Permanente Northern California in Oakland, and colleagues examined whether higher diet quality at breast cancer diagnosis was related to a lower risk for CVD and CVD-related death in a prospective cohort of women diagnosed with invasive breast cancer between 2005 and 2013. At the time of breast cancer diagnosis, scores from five diet quality indices consistent with healthy eating were obtained. For each diet quality index, the scores were classified into ascending quartiles of concordance.

The researchers found a significantly lower risk for heart failure, arrhythmia, cardiac arrest, valvular heart disease, venous thromboembolic disease, and CVD-related death when comparing the highest with the lowest quartiles of the Dietary Approaches to Stop Hypertension diet quality index. There were also inverse associations for the healthy plant-based dietary index with heart failure (hazard ratio, 0.60) and for the alternate Mediterranean dietary index with arrhythmia (hazard ratio, 0.74).

"Implementing diets concordant with healthy dietary patterns may be beneficial for preventing CVD and CVD-related deaths for breast cancer patients, who have been shown to be at higher risk of CVD as compared with the general population," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Inavolisib + Palbociclib-Fulvestrant Improves Survival in Advanced Breast Cancer

THURSDAY, Oct. 31, 2024 -- Inavolisib plus palbociclib-fulvestrant yields significantly longer progression-free survival than placebo plus palbociclib-fulvestrant in patients with...

Early Aortic Valve Intervention Not Beneficial for Severe Aortic Stenosis

THURSDAY, Oct. 31, 2024 -- For patients with asymptomatic severe aortic stenosis and myocardial fibrosis, early aortic valve intervention does not impact all-cause death or...

ASN: Hypertension Most Common Cardiovascular Comorbidity Seen With Dialysis

WEDNESDAY, Oct. 30, 2024 -- Hypertension is the most common cardiovascular disease (CVD) comorbidity seen among dialysis patients globally, according to a study presented at...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.